Literature DB >> 2193721

The appropriate use of inotropes in shock.

M H Rosenthal1.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2193721     DOI： 10.1007/bf03006275

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN： 0832-610X            Impact factor:   5.063


× No keyword cloud information.
  10 in total

Review 1.  Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model.

Authors:  D R Sibley; R J Lefkowitz
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

2.  Effect of the calcium entry blocker verapamil on renal ischemia.

Authors:  J L Woolley; G R Barker; W K Jacobsen; G A Gingrich; S C Stewart; B A Briggs; R D Martin; R A Melashenko
Journal:  Crit Care Med       Date:  1988-01       Impact factor: 7.598

3.  Dose-related hemodynamic and renal effects of dopamine in congestive heart failure.

Authors:  J Beregovich; C Bianchi; S Rubler; E Lomnitz; N Cagin; B Levitt
Journal:  Am Heart J       Date:  1974-05       Impact factor: 4.749

4.  Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.

Authors:  R R Tuttle; J Mills
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

5.  Comparison of dobutamine and dopamine in treatment of severe heart failure.

Authors:  J D Stoner; J L Bolen; D C Harrison
Journal:  Br Heart J       Date:  1977-05

6.  Oxygen delivery and consumption in patients with hyperdynamic septic shock.

Authors:  M E Astiz; E C Rackow; J L Falk; B S Kaufman; M H Weil
Journal:  Crit Care Med       Date:  1987-01       Impact factor: 7.598

7.  In vitro evidence for dopaminergic receptors in human renal artery.

Authors:  S Ueda; S Yano; M Sakanashi
Journal:  J Cardiovasc Pharmacol       Date:  1982 Jan-Feb       Impact factor: 3.105

8.  Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man.

Authors:  T H LeJemtel; E Keung; E H Sonnenblick; H S Ribner; M Matsumoto; R Davis; W Schwartz; A A Alousi; D Davolos
Journal:  Circulation       Date:  1979-06       Impact factor: 29.690

9.  Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy.

Authors:  G L Schaer; M P Fink; J E Parrillo
Journal:  Crit Care Med       Date:  1985-06       Impact factor: 7.598

10.  Hemodynamic assessment of amrinone. A new inotropic agent.

Authors:  J R Benotti; W Grossman; E Braunwald; D D Davolos; A A Alousi
Journal:  N Engl J Med       Date:  1978-12-21       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.